Assessing technologies that are not cost-effective at a zero price report by the Decision Support Unit
There are several scenarios under which clinically effective technologies may be found not to be cost-effective even if they are zero priced. There may be costs associated with delivering the technology which remain even when the price is reduced to zero and these costs alone may outweigh the health...
| Main Author: | |
|---|---|
| Corporate Author: | |
| Format: | eBook |
| Language: | English |
| Published: |
[London]
National Institute for Health and Care Excellence (NICE)
2014, July 2014
|
| Subjects: | |
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Table of Contents:
- Includes bibliographical references